ETHICAL DECISION MAKING INTELLIGENCE (EDMI)
FOSTERING INNOVATION & SAFEGUARDING AI TECHNOLOGY IN PHARMA & LIFESCIENCES SECTOR
In our digital age, the rapid deployment of digital and AI technologies within companies fosters innovation and efficiency. However, these advancements also heighten the risks of privacy violations, unfair societal representation (e.g., through biased predictive modeling), and intransparent and non-verifiable decision-making.
EDMI (Ethical Decision Making Intelligence) prepares companies through education & awareness to deploy these technologies ethically and responsibly; fostering innovation and safeguarding Digital & AI systems.
EDMI currently focuses Pharma & Life Sciences sector; though many modules can be used across the sectors.
EDMI is a Swiss-based initiative that brings together industry, academia, and entrepreneurship. Supported by
-
Innosuisse and the University of Zurich, our research focuses on understanding the specific needs of Pharma and Life Sciences companies.
-
The ZHAW Institute of Computational Life Sciences provides the educational foundation for the program.
As we continue to develop EDMI, we are actively seeking collaborations with select pharmaceutical companies to deploy EDMI alongside advanced AI solutions.
- Our Collaborators -
- Our Education Modules -
As part of our Learning Intelligence initiative, EDMI offers a range of educational modules designed to help companies proactively implement digital and AI solutions. Tailored to different target groups, our modules provide strategic insights, and business-oriented approaches, and engage in forward-looking discussions about the future of technology.
If you're interested in bringing these modules to your organization or institution, please contact us for more information.
- Our Thought Leadership -
- Our Experts (Innosuisse Funded) -
Founder & CEO; Philosophy, Meaning, Strategy
Lab Sciences, Digital Ethics, Technopark
Senior Science Manager, Algorithmic Fairness, Digital Society Initiative
